C12Y 306/05002
Small monomeric gtpase
Official title: Small monomeric GTPase (3.6.5.2)
C12Y306/05002 (Small monomeric gtpase) appears on 70 US grants and 139 published applications in this corpus.
Search patents in C12Y- Granted patents
- 70
- Published applications
- 139
- Assignees
- 96
- Inventors
- 304
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 2 |
| 2005 | 0 | 2 |
| 2006 | 0 | 2 |
| 2007 | 0 | 0 |
| 2008 | 0 | 3 |
| 2009 | 0 | 2 |
| 2010 | 1 | 0 |
| 2011 | 2 | 3 |
| 2012 | 1 | 2 |
| 2013 | 0 | 1 |
| 2014 | 3 | 5 |
| 2015 | 2 | 9 |
| 2016 | 8 | 6 |
| 2017 | 5 | 8 |
| 2018 | 3 | 5 |
| 2019 | 3 | 3 |
| 2020 | 7 | 5 |
| 2021 | 3 | 6 |
| 2022 | 4 | 13 |
| 2023 | 5 | 13 |
| 2024 | 9 | 8 |
| 2025 | 4 | 22 |
| 2026 | 9 | 19 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Genetically engineered phagocytes, and related compositions, vectors, methods and systems22 Sep 2026US 12,741,025 B2The Regents of the University of California
- Methods and compositions for the expression of constitutively active RAP1A from a VMD2 promoter25 Aug 2026US 12,714,757 B2University of Flordia Research Foundation, Inc.
- Methods for inducing full ablation of hematopoiesis14 Jul 2026US 12,678,491 B2Assistance Publique-HôPitaux De Paris (Aphp)
- HLA class II-restricted DRB T cell receptors against RAS with G12V mutation16 Jun 2026US 12,655,194 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Mutants of a filamentous fungal cell having increased productivity in the production of a polypeptide12 May 2026US 12,624,376 B2Novozymes A/S
- Nonsense mediated decay inhibitor compounds17 Sep 2026US 2026/0272923 A1The Johns Hopkins University
- Optimized antisense sequences that enhance targeted rna editing by adar proteins20 Aug 2026US 2026/0242790 A1The Board of Trustees of the Leland Stanford Junior University
- Compositions and methods for generating porcine ovarian tumor model6 Aug 2026US 2026/0223823 A1Georgia Tech Research Corporation
- Compositions for modulating kras expression and uses thereof6 Aug 2026US 2026/0226472 A1Molecular Axiom, LLC
- Antigenic peptide having multiple kras variant peptides linked thereto, nucleic acid encoding the same, and use thereof23 Jul 2026US 2026/0207724 A1Hanmi Pharm. Co., Ltd.
Most cited
By later US patents
- Method for screening inhibitors of Ras41US 9,810,690 B2Araxes Pharma LLC · 2017
- Compositions and methods for treating cancer28US 10,023,588 B2The Regents of the University of California · 2018
- Upregulation of Type III endothelial cell nitric oxide synthase by rho GTPase function inhibitors25US 6,180,597 B2The Brigham and Women S Hospital, Inc. · 2001
- Compositions and methods for treating cancer19US 11,008,334 B2The Regents of the University of California · 2021
- High resolution melting analysis as a prescreening tool13US 10,023,917 B2Roche Molecular Systems, Inc. · 2018